immunotherapy

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved teprizumab (Tzield, Aventis Pharma Limited) as the UK's first immunotherapy for type 1 diabetes (T1D). The drug is approved for …

Introduction Diabetes Mellitus is a chronic metabolic disease causing those with the condition to be subjected to higher blood glucose ranges compared to healthy controls. According to the World Health …

credit: autoimmune journal (2024). DOI: 10.1016/j.jaut.2024.103196 Researchers at Germany’s Institut Trias i Puyol (IGTP) and Ahead Therapeutics SL have been researching liposomal nanoparticle-based therapies to combat autoimmunity in type 1 …

Diamyd is an antigen-specific immunotherapy that preserves insulin-producing beta cells. Image credit: Image Point Fr / Shutterstock. Swedish biotech Diamyd has received Fast Track designation from the US Food and …